Elder Pharmaceuticals has entered into a strategic alliance with UK's Medichem International to develop, manufacture and market advanced medical biosecurity products in India.
Medichem is a leader in advanced medical disinfection products. It sells in more than 40 countries. Through the alliance, Elder would initially market a disinfectant spray developed by Medichem International, used for precaution against the potential risk from H5N1 avian flu virus.
Branded as Trigene, the new disinfectant is certified by the Department for Environment Food and Rural Affairs - the apex British government body for such products - as effective against bird flu viruses at normal user dilutions.
Medichem International, based at Kent in UK, develops, manufactures and markets advanced chemical biosecurity products. Since 1992, the company has been enhancing the infection control needs of many markets with a range of revolutionary products.
Sources in the company said that Trigene is effective in containing the spread of bird flu in hospitals, poultry farms, kennels, catteries and other animal habitats and has met with tremendous success since its launch last year, particularly in China.
In view of responses received from a few hospitals in Mumbai, Elder is working out plans to manufacture this - and other similar products from Medichem - in India at its newly set up US FDA compliant Uttaranchal facility.
Alok Saxena, director, Elder Pharmaceuticals, said "Elder's entry into the medical disinfection sector is a part of our strategy of focusing on emerging segments and manufacturing world class products in India through licenses with global majors."
He added that once it starts manufacturing these products, Elder plans to take them to the markets in the medical segment, which include the laboratories, veterinary, environmental, military and government segments within the country, in the current year.Do you want to discuss stock tips? Do you know a hot one? Join the Stock Market Investments Discussion Group
